157 related articles for article (PubMed ID: 35047578)
1. Arrhythmia Patterns in Patients on Ibrutinib.
Fazal M; Kapoor R; Cheng P; Rogers AJ; Narayan SM; Wang P; Witteles RM; Perino AC; Baykaner T; Rhee JW
Front Cardiovasc Med; 2021; 8():792310. PubMed ID: 35047578
[No Abstract] [Full Text] [Related]
2. Comparative arrhythmia patterns among patients on tyrosine kinase inhibitors.
Wei C; Fazal M; Loh A; Kapoor R; Gomez SE; Shah S; Rogers AJ; Narayan SM; Wang PJ; Witteles RM; Perino AC; Cheng P; Rhee JW; Baykaner T
J Interv Card Electrophysiol; 2024 Jan; 67(1):111-118. PubMed ID: 37256462
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase inhibitor-associated ventricular arrhythmias: a case series and review of literature.
Fazal M; Wei C; Chuy KL; Hussain K; Gomez SE; Ba SS; Pietrasik G; Yadav N; Ghazizadeh Z; Kapoor R; Witteles RM; Blackmon A; Wang PJ; John RM; Narayan SM; Cheng P; Rhee JW; Baykaner T
J Interv Card Electrophysiol; 2023 Aug; 66(5):1165-1175. PubMed ID: 36411365
[TBL] [Abstract][Full Text] [Related]
4. Ibrutinib and Bruton's Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Focus on Atrial Fibrillation and Ventricular Tachyarrhythmias/Sudden Cardiac Death.
Boriani G; Menna P; Morgagni R; Minotti G; Vitolo M
Chemotherapy; 2023; 68(2):61-72. PubMed ID: 36366814
[TBL] [Abstract][Full Text] [Related]
5. Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with Ibrutinib.
Avalon JC; Fuqua J; Miller T; Deskins S; Wakefield C; King A; Inderbitzin-Brooks S; Bianco C; Veltri L; Fang W; Craig M; Kanate A; Ross K; Malla M; Patel B
Cardiooncology; 2021 Nov; 7(1):38. PubMed ID: 34798905
[TBL] [Abstract][Full Text] [Related]
6. Advanced electrophysiologic mapping systems: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
[TBL] [Abstract][Full Text] [Related]
7. Determinants of Atrial Fibrillation Development among Patients undergoing Ibrutinib Therapy.
Onitilo AA; Piwuna TO; Islam N; Furuya-Kanamori L; Kumar S; Doi SAR
Clin Med Res; 2022 Mar; 20(1):16-22. PubMed ID: 35022197
[No Abstract] [Full Text] [Related]
8. Arrhythmogenic Cardiotoxicity Associated With Contemporary Treatments of Lymphoproliferative Disorders.
Sherazi S; Schleede S; McNitt S; Casulo C; Moore JE; Storozynsky E; Patel A; Vidula N; Aktas MK; Zent CS; Goldenberg I
J Am Heart Assoc; 2023 Mar; 12(6):e025786. PubMed ID: 36892046
[TBL] [Abstract][Full Text] [Related]
9. Management of Atrial Fibrillation in Patients on Ibrutinib: A Cleveland Clinic Experience.
Khalid S; Yasar S; Khalid A; Spiro TP; Haddad A; Daw H
Cureus; 2018 May; 10(5):e2701. PubMed ID: 30062075
[TBL] [Abstract][Full Text] [Related]
10. Consequences of chronic frequent premature atrial contractions: Association with cardiac arrhythmias and cardiac structural changes.
Gunda S; Akyeampong D; Gomez-Arroyo J; Jovin DG; Kowlgi NG; Kaszala K; Tan AY; Koneru JN; Kron J; Ellenbogen KA; Huizar JF
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1952-1959. PubMed ID: 31310360
[TBL] [Abstract][Full Text] [Related]
11. Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials.
Brown JR; Moslehi J; O'Brien S; Ghia P; Hillmen P; Cymbalista F; Shanafelt TD; Fraser G; Rule S; Kipps TJ; Coutre S; Dilhuydy MS; Cramer P; Tedeschi A; Jaeger U; Dreyling M; Byrd JC; Howes A; Todd M; Vermeulen J; James DF; Clow F; Styles L; Valentino R; Wildgust M; Mahler M; Burger JA
Haematologica; 2017 Oct; 102(10):1796-1805. PubMed ID: 28751558
[TBL] [Abstract][Full Text] [Related]
12. Ablation for atrial fibrillation: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(7):1-63. PubMed ID: 23074498
[TBL] [Abstract][Full Text] [Related]
13. Ibrutinib-related atrial fibrillation: A single center Australian experience.
Ezad S; Khan AA; Cheema H; Ashraf A; Ngo DTM; Sverdlov AL; Collins NJ
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e187-e190. PubMed ID: 31250562
[TBL] [Abstract][Full Text] [Related]
14. Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke.
Narezkina A; Akhter N; Lu X; Emond B; Panjabi S; Forbes SP; Hilts A; Liu S; Lafeuille MH; Lefebvre P; Huang Q; Choi M
Clin Lymphoma Myeloma Leuk; 2022 Nov; 22(11):e959-e971. PubMed ID: 35973891
[TBL] [Abstract][Full Text] [Related]
15. Bruton's tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation.
Sestier M; Hillis C; Fraser G; Leong D
Curr Oncol Rep; 2021 Aug; 23(10):113. PubMed ID: 34342738
[TBL] [Abstract][Full Text] [Related]
16. Acute Effects of Ibrutinib on Ventricular Arrhythmia in Spontaneously Hypertensive Rats.
Du B; Chakraborty P; Azam MA; Massé S; Lai PFH; Niri A; Si D; Thavendiranathan P; Abdel-Qadir H; Billia F; Nanthakumar K
JACC CardioOncol; 2020 Nov; 2(4):614-629. PubMed ID: 34396273
[TBL] [Abstract][Full Text] [Related]
17. High incidence of atrial fibrillation in patients treated with ibrutinib.
Baptiste F; Cautela J; Ancedy Y; Resseguier N; Aurran T; Farnault L; Escudier M; Ammar C; Gaubert M; Dolladille C; Barraud J; Peyrol M; Cohen A; Paganelli F; Alexandre J; Ederhy S; Thuny F
Open Heart; 2019; 6(1):e001049. PubMed ID: 31168393
[TBL] [Abstract][Full Text] [Related]
18. Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase.
Xiao L; Salem JE; Clauss S; Hanley A; Bapat A; Hulsmans M; Iwamoto Y; Wojtkiewicz G; Cetinbas M; Schloss MJ; Tedeschi J; Lebrun-Vignes B; Lundby A; Sadreyev RI; Moslehi J; Nahrendorf M; Ellinor PT; Milan DJ
Circulation; 2020 Dec; 142(25):2443-2455. PubMed ID: 33092403
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for the development of atrial fibrillation on ibrutinib treatment.
Lentz R; Feinglass J; Ma S; Akhter N
Leuk Lymphoma; 2019 Jun; 60(6):1447-1453. PubMed ID: 30730240
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation.
Edwards SJ; Wakefield V; Jhita T; Kew K; Cain P; Marceniuk G
Health Technol Assess; 2020 Jan; 24(5):1-184. PubMed ID: 31944175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
